Monitor this situation.
Unsubscribe anytime.
[SITUATION] · [ACTIVE] · [HEALTH]
2 clusters · 3 sources · 9 days · First seen · Last updated
Pharmaceutical service disruptions in Spain and Colombia
Overview
In early November 2026, pharmaceutical services faced potential disruptions in two different regions. In Spain, the Official College of Pharmacists of Madrid announced that pharmacies would remain open during a general strike scheduled for November 11, with various autonomous communities approving minimum services to preserve healthcare assistance. Simultaneously, the Colombian Medical College issued an alert regarding risks to patient treatments in Colombia, warning that administrative and logistical changes within Health Promoting Entities could delay medication dispensing for patients with cancer or orphan diseases.
By mid-November, the focus in Spain shifted toward specific supply shortages. The Spanish Agency for Medicines and Health Products identified 918 medication presentations facing shortages. While health sources indicated that alternative medications with the same active ingredients are often available, the agency has authorized exceptional commercialization for certain products. In Galicia, authorities continue to use long-standing monitoring mechanisms to track stocks and anticipate supply issues, with recovery timelines for some shortages extending into 2027.
Entities
Spain · Galicia · Spanish Agency for Medicines and Health Products · Official College of Pharmacists of Madrid · Colombia
Timeline
-
[HEALTH] 3 sourcesSpain reports supply issues for nearly 1,000 medication presentations
Spain's AEMPS reports 918 medication presentations with supply issues. While some shortages persist, alternatives are often available, and Sergas uses a decade-old monitoring system to manage impacts.
-
[HEALTH] 2 sourcesPharmaceutical services face disruptions in Spain and Colombia
Pharmacists in Spain plan to remain open during a November general strike, while the Colombian Medical College warns of treatment risks due to changes in pharmaceutical operators.
Sources
galiciapress.es · laopinioncoruna.es · ocio.farodevigo.es